Dow Jones

39,806.77

-0.49%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ACTI

Actividentity Corp (MM) (ACTI)

Actividentity Corp (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACTI

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
23/05/2019	13:00	GlobeNewswire	Annual General Meeting of Active Biotech AB	NASDAQ:ACTI	Actividentity Corp (MM)
03/05/2019	06:00	GlobeNewswire	The Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Ac...	NASDAQ:ACTI	Actividentity Corp (MM)
02/05/2019	06:00	GlobeNewswire	The Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksel...	NASDAQ:ACTI	Actividentity Corp (MM)
26/04/2019	04:00	GlobeNewswire	Annual Report 2018 Active Biotech AB (publ)	NASDAQ:ACTI	Actividentity Corp (MM)
25/04/2019	01:30	GlobeNewswire	Active Biotech AB - Interim report January - March 2019	NASDAQ:ACTI	Actividentity Corp (MM)
24/04/2019	06:00	GlobeNewswire	Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	NASDAQ:ACTI	Actividentity Corp (MM)
05/04/2019	07:15	GlobeNewswire	Active Biotech completes sale of property	NASDAQ:ACTI	Actividentity Corp (MM)
04/04/2019	11:00	GlobeNewswire	Extraordinary General Meeting of Active Biotech AB	NASDAQ:ACTI	Actividentity Corp (MM)
13/03/2019	12:15	GlobeNewswire	NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)	NASDAQ:ACTI	Actividentity Corp (MM)
13/03/2019	12:00	GlobeNewswire	Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on Apri...	NASDAQ:ACTI	Actividentity Corp (MM)
14/02/2019	01:30	GlobeNewswire	Active Biotech Year-end report January - December 2018	NASDAQ:ACTI	Actividentity Corp (MM)
11/02/2019	07:00	GlobeNewswire	Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI...	NASDAQ:ACTI	Actividentity Corp (MM)
01/02/2019	09:15	GlobeNewswire	Active Biotech has received an indicative bid for the property in Lund - the Board is positive	NASDAQ:ACTI	Actividentity Corp (MM)
10/12/2018	05:30	GlobeNewswire	Active Biotech provides updated information about the company's financial position	NASDAQ:ACTI	Actividentity Corp (MM)
19/11/2018	01:30	GlobeNewswire	Active Biotech's election committee appointed	NASDAQ:ACTI	Actividentity Corp (MM)
14/11/2018	14:30	GlobeNewswire	Active Biotech AB - Interim report January - September 2018	NASDAQ:ACTI	Actividentity Corp (MM)
08/11/2018	06:00	GlobeNewswire	Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018	NASDAQ:ACTI	Actividentity Corp (MM)
13/09/2018	04:00	GlobeNewswire	Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Hu...	NASDAQ:ACTI	Actividentity Corp (MM)
05/09/2018	01:30	GlobeNewswire	Active Biotech regains global rights to development and commercialization of laquinimod	NASDAQ:ACTI	Actividentity Corp (MM)
09/08/2018	01:30	GlobeNewswire	Active Biotech AB - Interim Report January - June 2018	NASDAQ:ACTI	Actividentity Corp (MM)
31/07/2018	02:15	GlobeNewswire	Active Biotech provides update on laquinimod in Huntington's disease	NASDAQ:ACTI	Actividentity Corp (MM)
31/05/2018	01:30	GlobeNewswire	Number of shares and votes in Active Biotech	NASDAQ:ACTI	Actividentity Corp (MM)
17/05/2018	09:00	GlobeNewswire	Active Biotech AB Interim report January - March 2018	NASDAQ:ACTI	Actividentity Corp (MM)
23/04/2018	04:30	GlobeNewswire	Annual Report 2017 Active Biotech AB (publ)	NASDAQ:ACTI	Actividentity Corp (MM)
18/04/2018	09:10	GlobeNewswire	Active Biotech: Notice of Annual General Meeting of Shareholders	NASDAQ:ACTI	Actividentity Corp (MM)
16/04/2018	05:40	GlobeNewswire	Active Biotech's rights issue over subscribed	NASDAQ:ACTI	Actividentity Corp (MM)
12/04/2018	06:00	GlobeNewswire	Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blocka...	NASDAQ:ACTI	Actividentity Corp (MM)
27/03/2018	02:39	GlobeNewswire	Prospectus relating to Active Biotech's rights issue published	NASDAQ:ACTI	Actividentity Corp (MM)
15/02/2018	03:10	GlobeNewswire	Active Biotech announces rights issue of approximately SEK 48 million	NASDAQ:ACTI	Actividentity Corp (MM)
15/02/2018	01:40	GlobeNewswire	NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING	NASDAQ:ACTI	Actividentity Corp (MM)